RTC
PRTA icon

Riverview Trust Company’s Prothena Corp PRTA Stock Holding History

Riverview Trust Company’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-659
Closed -$16.3K – 658
2024
Q1 		$16.3K Buy
+659
New +$19.6K 0.01% 563

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Riverview Trust Company's PRTA Position: Q2 2024 in Review

Riverview Trust Company sold out of Prothena Corp (PRTA) in Q2 2024, closing a stake of 659 shares — an estimated $16.3K sold.

Riverview Trust Company first reported a position in PRTA in Q1 2024 and held it in 1 quarter. The position peaked at $16.3K in Q1 2024. 160 funds tracked by Wall St. Rank hold PRTA as of Q2 2024.

  • Riverview Trust Company reported no remaining Prothena Corp position as of Q2 2024 after selling out during the quarter.
  • Riverview Trust Company sold 659 Prothena Corp shares in Q2 2024, an estimated $16.3K.
  • Riverview Trust Company first reported a position in Prothena Corp in Q1 2024 and held it in 1 quarter.
  • Riverview Trust Company's Prothena Corp position peaked at $16.3K in Q1 2024.
  • 160 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2024.

Based on Riverview Trust Company's 13F filing for Q2 2024, filed 16 Jul 2024.